This study has unveiled a novel finding that tumor cell-derived LMW-HA-induced S1PR1 endocytosis could trigger lymphangiogenesis, in which LYVE-1-mediated enhancement of Src phosphorylation may be responsible for the underlying mechanism. The gene discussed is LYVE1; the disease is neoplasm.